Castellan Group’s Eli Lilly LLY Stock Holding History

Castellan Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,724	Closed	-$1.26M	–	79
2021 Q1	$1.26M	Buy	+6,724	New	+$1.32M	0.67%	51

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Castellan Group's LLY Position: Q2 2021 in Review

Castellan Group sold out of Eli Lilly (LLY) in Q2 2021, closing a stake of 6,724 shares — an estimated $1.26M sold.

Castellan Group first reported a position in LLY in Q1 2021 and held it in 1 quarter. The position peaked at $1.26M in Q1 2021. 2,021 funds tracked by Wall St. Rank hold LLY as of Q2 2021.

Castellan Group reported no remaining Eli Lilly position as of Q2 2021 after selling out during the quarter.
Castellan Group sold 6,724 Eli Lilly shares in Q2 2021, an estimated $1.26M.
Castellan Group first reported a position in Eli Lilly in Q1 2021 and held it in 1 quarter.
Castellan Group's Eli Lilly position peaked at $1.26M in Q1 2021.
2,021 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.

Based on Castellan Group's 13F filing for Q2 2021, filed 16 Aug 2021.